Successful external validation of a model to predict other cause mortality in localized prostate cancer.
AUTHORS
Kent
M ,
Penson
DF ,
Albertsen
PC ,
Goodman
M ,
Hamilton
AS ,
Stanford
JL ,
Stroup
AM ,
Ehdaie
B ,
Scardino
PT ,
Vickers
AJ ,
. BMC medicine. 2016 1 1; 14(1). 25
- PMID: 26860993 [PubMed].
- PMCID: PMC4748497.
ABSTRACT
Although life expectancy estimation is vital to decision making for localized prostate cancer, there are few, if any, valid and usable tools. Our goal was to create and validate a prediction model for other cause mortality in localized prostate cancer patients that could aid clinician’s initial treatment decisions at the point of care.
Although life expectancy estimation is vital to decision making for localized prostate cancer, there are few, if any, valid and usable tools. Our goal was to create and validate a prediction model for other cause mortality in localized prostate cancer patients that could aid clinician’s initial treatment decisions at the point of care.
Tags: Alumni Publications 2016